A prospective study of salvage high-intensity focused ultrasound for locally radiorecurrent prostate cancer: Early results
Authors:
- 30 March 2010
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Urology and Nephrology
- Vol. 44 (4) , 223-227
Abstract
Objective. After radical external beam radiation therapy (EBRT), local recurrence may benefit from definitive local therapy. The objective of this study was to evaluate the safety and short-term biochemical results and morbidity after salvage high-intensity focused ultrasound (HIFU) treatment in patients with biopsy-proven local prostate cancer recurrence after EBRT. Material and methods. From October 2006 46 patients were treated with HIFU. Bone scan and abdominal CT/MRI scan were negative. Median follow-up was 9 months (range 3–24 months). Results. The median prostate-specific antigen (PSA) nadir was 0.3 ng/ml (range 0–24 ng/ml). Eighteen patients (39.1%) were classified as failures. In addition, there were four patients (8.7%) with post-HIFU PSA nadir > 0.5 ng/ml. No patients died during follow-up. One patient developed urethrorectal fistulae and was successfully treated conservatively. Two patients developed urethrocutaneous fistulae. Seven patients (15.2%) and one patient (2.1%) developed grade 2 and grade 3 incontinence, respectively. Seven men (15.2%) had erectile function sufficient for intercourse pre-HIFU and only two men (4.3%) post-HIFU. Conclusions. Early results of salvage HIFU in patients with local recurrence of prostate cancer after radical EBRT indicate the procedure to be a reasonable treatment option, but better patient selection criteria are needed. The side-effects are not negligible.Keywords
This publication has 13 references indexed in Scilit:
- Prognostic Parameters, Complications, and Oncologic and Functional Outcome of Salvage Radical Prostatectomy for Locally Recurrent Prostate Cancer after 21st-Century RadiotherapyEuropean Urology, 2010
- Mid-term Results Demonstrate Salvage High-Intensity Focused Ultrasound (HIFU) as an Effective and Acceptably Morbid Salvage Treatment Option for Locally Radiorecurrent Prostate CancerEuropean Urology, 2009
- Cryosurgery for Prostate Cancer: an Update on Clinical Results of Modern CryotechnologyEuropean Urology, 2009
- SALVAGE HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) THERAPY FOR LOCALLY RECURRENT PROSTATE CANCER AFTER PRIMARY HIFU OR EXTERNAL BEAM RADIOTHERAPY (EBRT)European Urology Supplements, 2008
- Impact of disseminated tumor cells in bone marrow at diagnosis in patients with nonmetastatic prostate cancer treated by definitive radiotherapyInternational Journal of Cancer, 2007
- CURRENT STATUS OF LOCAL SALVAGE THERAPIES FOLLOWING RADIATION FAILURE FOR PROSTATE CANCERJournal of Urology, 2005
- Long-term multi-institutional analysis of stage T1–T2 prostate cancer treated with radiotherapy in the PSA eraInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003
- Serial Histopathology Results of Salvage Cryoablation for Prostate Cancer after Radiation FailureJournal of Urology, 2003
- Postradiotherapy prostate biopsies: what do they really mean? results for 498 patientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000
- Prostate Specific Antigen After Radiotherapy for Prostate Cancer: A Reevaluation of Long-Term Biochemical Control and Kinetics of Recurrence in Patients Treated at Stanford UniversityJournal of Urology, 1995